We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) closed at $250.76 in the latest trading session, marking a +0.51% move from the prior day. This move lagged the S&P 500's daily gain of 1.42%. Meanwhile, the Dow gained 1%, and the Nasdaq, a tech-heavy index, added 5.16%.
Prior to today's trading, shares of the company had gained 8.76% over the past month. This has outpaced the Medical sector's gain of 1.28% and the S&P 500's gain of 0.27% in that time.
Investors will be hoping for strength from Intuitive Surgical, Inc. as it approaches its next earnings release, which is expected to be April 18, 2023. The company is expected to report EPS of $1.18, up 4.42% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.58 billion, up 6.51% from the year-ago period.
ISRG's full-year Zacks Consensus Estimates are calling for earnings of $5.27 per share and revenue of $6.88 billion. These results would represent year-over-year changes of +12.61% and +10.65%, respectively.
Investors might also notice recent changes to analyst estimates for Intuitive Surgical, Inc.These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.96% lower. Intuitive Surgical, Inc. is currently a Zacks Rank #4 (Sell).
In terms of valuation, Intuitive Surgical, Inc. is currently trading at a Forward P/E ratio of 47.34. This valuation marks a premium compared to its industry's average Forward P/E of 24.85.
Also, we should mention that ISRG has a PEG ratio of 3.97. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. ISRG's industry had an average PEG ratio of 2.09 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 75, putting it in the top 30% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know
Intuitive Surgical, Inc. (ISRG - Free Report) closed at $250.76 in the latest trading session, marking a +0.51% move from the prior day. This move lagged the S&P 500's daily gain of 1.42%. Meanwhile, the Dow gained 1%, and the Nasdaq, a tech-heavy index, added 5.16%.
Prior to today's trading, shares of the company had gained 8.76% over the past month. This has outpaced the Medical sector's gain of 1.28% and the S&P 500's gain of 0.27% in that time.
Investors will be hoping for strength from Intuitive Surgical, Inc. as it approaches its next earnings release, which is expected to be April 18, 2023. The company is expected to report EPS of $1.18, up 4.42% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.58 billion, up 6.51% from the year-ago period.
ISRG's full-year Zacks Consensus Estimates are calling for earnings of $5.27 per share and revenue of $6.88 billion. These results would represent year-over-year changes of +12.61% and +10.65%, respectively.
Investors might also notice recent changes to analyst estimates for Intuitive Surgical, Inc.These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.96% lower. Intuitive Surgical, Inc. is currently a Zacks Rank #4 (Sell).
In terms of valuation, Intuitive Surgical, Inc. is currently trading at a Forward P/E ratio of 47.34. This valuation marks a premium compared to its industry's average Forward P/E of 24.85.
Also, we should mention that ISRG has a PEG ratio of 3.97. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. ISRG's industry had an average PEG ratio of 2.09 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 75, putting it in the top 30% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.